- Home
- KWE vs TTNP Comparison
KWE vs TTNP Comparison
Compare KWE & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWE
- TTNP
- Stock Information
- Founded
- KWE 2017
- TTNP 1991
- Country
- KWE Canada
- TTNP United States
- Employees
- KWE N/A
- TTNP N/A
- Industry
- KWE
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KWE
- TTNP Health Care
- Exchange
- KWE Nasdaq
- TTNP Nasdaq
- Market Cap
- KWE 3.2M
- TTNP 3.4M
- IPO Year
- KWE N/A
- TTNP 1996
- Fundamental
- Price
- KWE $5.14
- TTNP $3.70
- Analyst Decision
- KWE
- TTNP
- Analyst Count
- KWE 0
- TTNP 0
- Target Price
- KWE N/A
- TTNP N/A
- AVG Volume (30 Days)
- KWE 423.8K
- TTNP 9.7K
- Earning Date
- KWE 05-15-2025
- TTNP 05-14-2025
- Dividend Yield
- KWE N/A
- TTNP N/A
- EPS Growth
- KWE N/A
- TTNP N/A
- EPS
- KWE N/A
- TTNP N/A
- Revenue
- KWE $1,572,738.00
- TTNP N/A
- Revenue This Year
- KWE N/A
- TTNP N/A
- Revenue Next Year
- KWE N/A
- TTNP N/A
- P/E Ratio
- KWE N/A
- TTNP N/A
- Revenue Growth
- KWE 116.30
- TTNP N/A
- 52 Week Low
- KWE $0.22
- TTNP $3.03
- 52 Week High
- KWE $243.60
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- KWE 49.11
- TTNP 49.54
- Support Level
- KWE $0.22
- TTNP $3.53
- Resistance Level
- KWE $7.20
- TTNP $3.76
- Average True Range (ATR)
- KWE 0.64
- TTNP 0.20
- MACD
- KWE 0.17
- TTNP -0.00
- Stochastic Oscillator
- KWE 70.50
- TTNP 32.79
About KWE KWESST Micro Systems Inc.
KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.